Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
NHS England has published a proposed interim specification for the new services for children and young people experiencing gender dysphoria.
-
Information on the insertion of an inflatable penile prosthesis
-
The children's FGM service is a dedicated monthly multidisciplinary clinic for girls under 18 years old who have had, are suspected to have had, or who may be at risk of having, FGM.
-
This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a video or telephone appointment.
-
We’re delighted to announce that our Grafton Way Elective Surgical Hub has been successfully accredited as an elective surgical hub delivering high standards in clinical and operational practice.
-
UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.
-
More than 800 patients on waiting lists for Ear, Nose and Throat appointments across North Central London seen in two days during ENT surgery ‘super-weekend’
-
Dr Katherine Clesham is a consultant haematologist specialising in the treatment of teenagers and young adults with acute leukaemia and patients undergoing stem cell transplantation and CAR-T therapy.
-
The High Court has today (26 March) ruled that parents can consent on behalf of their child for hormone-blocking treatment in cases of gender dysphoria.
File results
-
FOI/2024/0509 - Structure chart for Estates and Facilities
-
FOI/2024/0511 - Radiotherapy treatment planning system/artificial intelligence (AI)/ costs
-
FOI/2024/0512 - Patient harm and the cost 2020-2023
-
FOI/2024/0513 - Robotic platforms for surgery costs/ contract
-
FOI/2024/0514 - Viscosupplementation injections/ spend
-
FOI/2024/0518 - Post partum balloons buying/ usage numbers
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0528 - Open MRIs referrals for patient size/ spend on specialist bariatric equipment 2017-2024